{
  "id": 335664,
  "title": "Will the test set be released?",
  "url": "/competitions/prostate-cancer-grade-assessment/discussion/335664",
  "author_name": "gaozeyu",
  "post_date": "2022-07-07T09:34:59.043000",
  "votes": 1,
  "comment_count": 1,
  "views": 0,
  "content": "<p>Will the \"public\" and \"private\" test sets be released?<br>\nSince the challenge paper is already published in Nature Medicine, can we use this dataset for further research?<br>\nThanks a lot!</p>",
  "messages": [
    {
      "id": 1846689,
      "postDate": "2022-07-07T09:34:59.043Z",
      "content": "<p>Will the \"public\" and \"private\" test sets be released?<br>\nSince the challenge paper is already published in Nature Medicine, can we use this dataset for further research?<br>\nThanks a lot!</p>",
      "rawMarkdown": "Will the \"public\" and \"private\" test sets be released?\nSince the challenge paper is already published in Nature Medicine, can we use this dataset for further research?\nThanks a lot!",
      "votes": 1
    },
    {
      "id": 1851433,
      "postDate": "2022-07-11T08:37:16.047Z",
      "content": "<p>Hi, the current plan is to not release the test sets, as this could lead to algorithms being over-optimized against these sets. It is still possible to submit late submission to the challenge and get the scores on the test sets, keeping PANDA useful for algorithm benchmarking. These results are of course fine to then report in a paper for example. </p>\n<p>The training data can be downloaded and used for further research in accordance with the CC BY-SA-NC 4.0 license (see <a href=\"https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)\" target=\"_blank\">https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)</a>.</p>",
      "rawMarkdown": "Hi, the current plan is to not release the test sets, as this could lead to algorithms being over-optimized against these sets. It is still possible to submit late submission to the challenge and get the scores on the test sets, keeping PANDA useful for algorithm benchmarking. These results are of course fine to then report in a paper for example. \n\nThe training data can be downloaded and used for further research in accordance with the CC BY-SA-NC 4.0 license (see https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)."
    }
  ],
  "comments": [
    {
      "id": 1851433,
      "author_name": "Kimmo Kartasalo",
      "author_url": "",
      "post_date": "2022-07-11T08:37:16.047000",
      "content": "<p>Hi, the current plan is to not release the test sets, as this could lead to algorithms being over-optimized against these sets. It is still possible to submit late submission to the challenge and get the scores on the test sets, keeping PANDA useful for algorithm benchmarking. These results are of course fine to then report in a paper for example. </p>\n<p>The training data can be downloaded and used for further research in accordance with the CC BY-SA-NC 4.0 license (see <a href=\"https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)\" target=\"_blank\">https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)</a>.</p>",
      "votes": 0,
      "replies": []
    }
  ],
  "raw_markdown_by_id": {
    "1846689": "Will the \"public\" and \"private\" test sets be released?\nSince the challenge paper is already published in Nature Medicine, can we use this dataset for further research?\nThanks a lot!",
    "1851433": "Hi, the current plan is to not release the test sets, as this could lead to algorithms being over-optimized against these sets. It is still possible to submit late submission to the challenge and get the scores on the test sets, keeping PANDA useful for algorithm benchmarking. These results are of course fine to then report in a paper for example. \n\nThe training data can be downloaded and used for further research in accordance with the CC BY-SA-NC 4.0 license (see https://www.kaggle.com/competitions/prostate-cancer-grade-assessment/discussion/300840)."
  }
}